Unveiling the Bioactive Potential of Boiss Bulb Flavonoids: Anti-cancer Activities, and Computational Exploration of Anti-angiogenic Mechanisms.
1/5 보강
[BACKGROUND] Plants of the genus show significant anti-cancer properties due to various phytochemicals, including flavonoids.
APA
Majnooni MB, Ghanadian M, et al. (2025). Unveiling the Bioactive Potential of Boiss Bulb Flavonoids: Anti-cancer Activities, and Computational Exploration of Anti-angiogenic Mechanisms.. Iranian journal of pharmaceutical research : IJPR, 24(1), e163152. https://doi.org/10.5812/ijpr-163152
MLA
Majnooni MB, et al.. "Unveiling the Bioactive Potential of Boiss Bulb Flavonoids: Anti-cancer Activities, and Computational Exploration of Anti-angiogenic Mechanisms.." Iranian journal of pharmaceutical research : IJPR, vol. 24, no. 1, 2025, pp. e163152.
PMID
41104251 ↗
Abstract 한글 요약
[BACKGROUND] Plants of the genus show significant anti-cancer properties due to various phytochemicals, including flavonoids.
[OBJECTIVES] This study investigated the cytotoxic activities of the methanolic extract of bulbs and its purified flavonoids. It also assessed the anti-angiogenic activities, a key mechanism of anti-cancer agents.
[METHODS] The methanolic extract was fractionated using column chromatography (CC) on silica gel RP-18 and polyamide SC-6, then purified with Sephadex LH-20. The compounds were identified through spectroscopic methods such as nuclear magnetic resonance (NMR) and liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS). Cytotoxicity and anti-angiogenic activities were evaluated using the MTT assay and the chick chorioallantoic membrane (CAM) assay, respectively. Computational modeling explored the potential anti-angiogenic mechanisms of the purified compounds. Additionally, absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling predicted drug-likeness features.
[RESULTS] Three flavonoids - quercetin 3-O-rutinoside (1), isorhamnetin 3-O-glucoside (2), and quercetin (3) - were isolated and identified. Compounds 2 and 3 showed the highest cytotoxicity against PC3 (prostate cancer, IC = 1.72 ± 0.11 µg/mL) and MCF-7 (breast cancer, IC = 1.64 ± 0.11 µg/mL) cell lines. The methanolic extract and compound 3 also had potent anti-angiogenic effects with IC values of 4.2 ± 0.25 and 5.3 ± 0.3 µg/mL, respectively. Molecular docking indicated that compounds 1 and 3 had the strongest interactions with the vascular endothelial growth factor receptor (VEGFR)-1, consistent with their anti-angiogenic activity. The ADMET profiling showed that compound 3 had the highest similarity to drug-like molecules.
[CONCLUSIONS] This was the first phytochemical study of flavonoids in bulbs. The results suggest that these bulbs could serve as a natural source for cancer prevention and treatment, owing to their cytotoxic and anti-angiogenic properties. Further research is needed to confirm these findings, and in vivo studies are essential to validate their therapeutic potential.
[OBJECTIVES] This study investigated the cytotoxic activities of the methanolic extract of bulbs and its purified flavonoids. It also assessed the anti-angiogenic activities, a key mechanism of anti-cancer agents.
[METHODS] The methanolic extract was fractionated using column chromatography (CC) on silica gel RP-18 and polyamide SC-6, then purified with Sephadex LH-20. The compounds were identified through spectroscopic methods such as nuclear magnetic resonance (NMR) and liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS). Cytotoxicity and anti-angiogenic activities were evaluated using the MTT assay and the chick chorioallantoic membrane (CAM) assay, respectively. Computational modeling explored the potential anti-angiogenic mechanisms of the purified compounds. Additionally, absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling predicted drug-likeness features.
[RESULTS] Three flavonoids - quercetin 3-O-rutinoside (1), isorhamnetin 3-O-glucoside (2), and quercetin (3) - were isolated and identified. Compounds 2 and 3 showed the highest cytotoxicity against PC3 (prostate cancer, IC = 1.72 ± 0.11 µg/mL) and MCF-7 (breast cancer, IC = 1.64 ± 0.11 µg/mL) cell lines. The methanolic extract and compound 3 also had potent anti-angiogenic effects with IC values of 4.2 ± 0.25 and 5.3 ± 0.3 µg/mL, respectively. Molecular docking indicated that compounds 1 and 3 had the strongest interactions with the vascular endothelial growth factor receptor (VEGFR)-1, consistent with their anti-angiogenic activity. The ADMET profiling showed that compound 3 had the highest similarity to drug-like molecules.
[CONCLUSIONS] This was the first phytochemical study of flavonoids in bulbs. The results suggest that these bulbs could serve as a natural source for cancer prevention and treatment, owing to their cytotoxic and anti-angiogenic properties. Further research is needed to confirm these findings, and in vivo studies are essential to validate their therapeutic potential.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The chick embryo chorioallantoic membrane as an experimental model to study lung cancer.
- Oral Poly(N-oxide) zwitterionic nanoplatform for Gambogenic Acid Enhances Mucosal penetration for potentiated anti-angiogenic therapy.
- Aminated fullerene-based nanoplatform enables synergistic VEGFR2-targeted anti-angiogenesis and tumor immunotherapy.
- The efficacy analysis of immunotherapy rechallenge after progression from first-line chemo-immunotherapy in advanced non-small cell lung cancer.
- The discovery of Bevacizumab. An historical reappraisal.
- Prognostic factors and quality of life in non-small cell lung cancer with leptomeningeal metastasis: a dichotomous pattern based on parenchymal involvement.